Novartis
NVS
NVS
1,137 hedge funds and large institutions have $18.2B invested in Novartis in 2022 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 413 increasing their positions, 414 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
0% less repeat investments, than reductions
Existing positions increased: 413 | Existing positions reduced: 414
1% less funds holding
Funds holding: 1,144 → 1,137 (-7)
1% less capital invested
Capital invested by funds: $18.5B → $18.2B (-$271M)
Holders
1,137
Holding in Top 10
6
Calls
$347M
Puts
$228M
Top Buyers
| 1 | +$99.7M | |
| 2 | +$88.7M | |
| 3 | +$52.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$45.9M |
| 5 |
CCM
Cullen Capital Management
New York
|
+$43.2M |
Top Sellers
| 1 | -$168M | |
| 2 | -$118M | |
| 3 | -$112M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$87.9M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$51.5M |